Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Hong Fei Gao"'
Autor:
Ying-Yi Lin, Hong-Fei Gao, Xin Yang, Teng Zhu, Xing-xing Zheng, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Publikováno v:
Breast, Vol 66, Iss , Pp 126-135 (2022)
Background: Evidence for the preferred neoadjuvant therapy regimen in triple-negative breast cancer (TNBC) is not yet established. Methods: Literature search was conducted from inception to February 12, 2022. Phase 2 and 3 randomized controlled trial
Externí odkaz:
https://doaj.org/article/829cec7249494b7f8529e46f948683ed
Autor:
Ya-xin Li, Hong-fei Gao, Rui-bin Zhang, Kutlwano Gabana, Qing Chang, Gillian A. Gehring, Xiao-hong Cheng, Xiang-bing Zeng, Goran Ungar
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
A 3D‐ordered liquid crystal phase of regular right and left helically twisted columns self‐assembles from straight‐ and bent‐rod molecules. Here calculations indicate that, among four alternative models, the observed complex Fddd structure pr
Externí odkaz:
https://doaj.org/article/a14df41a45414cbd99fcef1c14790f4c
Autor:
Hong-Fei Gao, Ying-Yi Lin, Teng Zhu, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Publikováno v:
Breast, Vol 59, Iss , Pp 165-175 (2021)
Background: The benefit of adjuvant cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors with endocrine therapy (ET) in hormone receptor-positive, human epidermal growth factor 2 receptor-negative (HR+/HER2-) early breast cancer (EBC) is uncertain. He
Externí odkaz:
https://doaj.org/article/7bcfd3ed4a5d448abe98e7be5702fc97
Autor:
Hong-Fei Gao, Wei-Ping Li, Teng Zhu, Ci-Qiu Yang, Mei Yang, Liu-Lu Zhang, Fei Ji, Min-Yi Cheng, Jie-Qing Li, Kun Wang
Publikováno v:
Breast, Vol 54, Iss , Pp 79-87 (2020)
Purpose: The aim of this study was to explore the value of adjuvant chemotherapy in patients with early-stage ER/PR-positive mucinous carcinoma. Methods: We identified early-stage ER/PR-positive mucinous carcinoma patients in the Surveillance, Epidem
Externí odkaz:
https://doaj.org/article/c25c9f3d0cdc4dccbc0abe00c86c86e0
Autor:
Hong-Fei Gao, Jun-Sheng Zhang, Qiang-Zu Zhang, Teng Zhu, Ci-Qiu Yang, Liu-Lu Zhang, Mei Yang, Fei Ji, Jie-Qing Li, Min-Yi Cheng, Gang Niu, Kun Wang
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Peritoneal metastases from invasive lobular carcinoma (ILC) of breast are uncommon and usually related to poor prognosis due to difficulty of detection in clinical practice and drug resistance. Therefore, recognizing the entities of peritoneal metast
Externí odkaz:
https://doaj.org/article/08d2d0bfd61347d6b3b17eeff08f7a51
Autor:
Fei Ji, Jiao-Mei Yuan, Hong-Fei Gao, Ai-Qi Xu, Zheng Yang, Ci-Qiu Yang, Liu-Lu Zhang, Mei Yang, Jie-Qing Li, Teng Zhu, Min-Yi Cheng, Si-Yan Wu, Kun Wang
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. Nonetheless, less study have determined the associations of different types of immune cells with patient survival and treatment response. In this stud
Externí odkaz:
https://doaj.org/article/1c3c4f4b26a446b090a90b93cd8895c6
Autor:
Hong-Fei Gao, Zhiyong Wu, Ying Lin, Xiang-Yang Song, Yin Cao, Qian-Jun Chen, Gangling Zhang, Peifen Fu, Zhenzhen Liu, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Teng Zhu, Fei Ji, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Although dual blockade HER2-based neoadjuvant chemotherapy is associated with excellent outcomes for human epidermal growth factor receptor 2 (HER2)-positive breast cancer, pertuzumab is not available to all patients due to cost. The opti
Externí odkaz:
https://doaj.org/article/d036c3fd9787471f81ac0cd6a23b620a
Autor:
Wei-Ping Li, Hong-Fei Gao, Fei Ji, Teng Zhu, Min-Yi Cheng, Mei Yang, Ci-Qiu Yang, Liu-Lu Zhang, Jie-Qing Li, Jun-Sheng Zhang, Kun Wang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background and aims: Male breast cancer is an uncommon disease. The benefit of adjuvant chemotherapy in the treatment of male breast cancer patients has not been determined. The aim of this study was to explore the value of adjuvant chemotherapy in m
Externí odkaz:
https://doaj.org/article/3aba07dd78f54e349b4a9177bb8b2ffc
Autor:
Junsheng Zhang, Hong-Fei Gao, Ciqiu Yang, Teng Zhu, Fei Ji, Mei Yang, Liulu Zhang, Jieqing Li, Minyi Cheng, Tingfeng Zhang, Bo Shen, Yuanqi Chen, Kun Wang
Publikováno v:
European Journal of Cancer. 171:150-160
For patients with breast cancer who receive docetaxel chemotherapy, taxane-associated acute pain syndrome (T-APS), considered a form of neural pathology, is a significant clinical problem. We evaluated the effect of prophylactic etoricoxib on T-APS i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f92b746912390a3ba2860c0c22c75cf
https://doi.org/10.1016/j.ejca.2022.05.019
https://doi.org/10.1016/j.ejca.2022.05.019
Autor:
Yuanqi Chen, Liulu Zhang, Minyi Cheng, Xiaosheng Zhuang, Ci-Qiu Yang, Fei Ji, Hong-Fei Gao, Mei Yang, Teng Zhu, Jieqing Li, Kun Wang
Publikováno v:
Cancer Research. 82:P1-08
Background: Recent studies have explored the potential role of homologous recombination deficiency (HRD) as a biomarker and shown that the HRD status may be related to the pCR rate. However, does HRD specifically predict the efficacy of platinum chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08d5d4f89aee77ee2276079acc029e94
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-32
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-32